Comparison between remifentanil and dexmedetomidine for sedation during modified awake fiberoptic intubation

Experimental and Therapeutic Medicine

Volumn 9, Issue 4, 2015, Pages 1259-1264

  Liu, Hui Hui ^a   Zhou, Tao ^b   Wei, Jian Qi ^a   Ma, Wu Hua ^a  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Awake fiberoptic intubation; Dexmedetomidine; Local anesthesia; Remifentanil

Indexed keywords

DEXMEDETOMIDINE; REMIFENTANIL;

ADULT; AIRWAY OBSTRUCTION; AMNESIA; ARTICLE; CAPNOMETRY; ENDOTRACHEAL INTUBATION; FEMALE; FIBEROPTIC BRONCHOSCOPY; FIBEROPTIC INTUBATION; HUMAN; HYPOXIA; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEDATION;

EID: 84922970391     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2015.2288     Document Type: Article

References (22)

1. Cafiero T, Esposito F, Fraioli G, et al: Remifentanil TCI and propofol TCI for conscious sedation during fibreoptic intubation in the acromegalic patient. Eur J Anaesthesiol 25: 670-674, 2008.
2. Péan D, Floch H, Beliard C, et al: Propofol versus sevoflurane for fiberoptic intubation under spontaneous breathing anesthesia in patients difficult to intubate. Minerva Anestesiol 76: 780-786, 2010.
3. Lallo A, Billard V and Bourgain JL: A comparison of propofol and remifentanil target controlled infusions to facilitate fiberoptic nasotracheal intubation. Anesth Analg 108: 852-857, 2009.
4. Boehm CA, Carney EL, Tallarida RJ, et al: Midazolam enhances the analgesic properties of dexmedetomidine in the rat. Vet Anaesth Analg 37: 550-556, 2010.
5. Belda I, Cubas MG, Rivas E, et al: Remifentanil target controlled infusion (TCI) vs ketamine or ketamine in combination with remifentanil TCI for conscious sedation in awake fiberoptic intubation: A randomized controlled trial: 19AP1 5. Eur J Anaesthesiol 28: 226, 2011.
6. Bürkle H, Dunbar S and Van Aken H: Remifentanil: a novel, short acting, mu opoid. Anesth Analg 83: 646-651, 1996.
7. Bergese SD, Khabiri B, Roberts WD, et al: Dexmedetomidine for conscious sedation in difficult awake fiberoptic intubation cases. J Clin Anesth 19: 141-144, 2007.
8. Madhere M, Vangura D and Saidov A: Dexmedetomidine as sole agent for awake fiberoptic intubation in a patient with local anesthetic allergy. J Anesth 25: 592-594, 2011.
9. Hu R, Liu JX and Jiang H: Dexmedetomidine versus remifentanil sedation during awake fiberoptic nasotracheal intubation: a double blinded randomized controlled trial. J Anesth 27: 211-217, 2013.
10. Chu KS, Wang FY, Hsu HT, et al: The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. Eur J Anaesthesiol 27: 36-40, 2010.
11. Xue FS, Liu HP, He N, et al: Spray as you go airway topical anesthesia in patients with a difficult airway: a randomized, double blind comparison of 2% and 4% lidocaine. Anesth Analg 108: 536-543, 2009.
12. Webb AR, Fernando SS, Dalton HR, et al: Local anaesthesia for fibreoptic bronchoscopy: transcricoid injection or the 'spray as you go' technique? Thorax 45: 474-477, 1990.
13. el Ganzouri AR, McCarthy RJ, Tuman KJ, et al: Preoperative airway assessment: predictive value of a multivariate risk index. Anesth Analg 82: 1197-1204, 1996.
14. Kundra P, Kutralam S and Ravishankar M: Local anaesthesia for awake fibreoptic nasotracheal intubation. Acta Anaesthesiol Scand 44: 511-516, 2000.
15. Sanchez A, Iyer RR and Morrison DE: Preparation of the patient for awake intubation. In: Benumof's Airway Management; Principles and Practice. Hagberg CA (ed). 2nd edition. Mosby Year Book, Inc., St. Louis, MO, pp263-277, 2007.
16. Vennila R, Hall A, Ali M, et al: Remifentanil as single agent to facilitate awake fibreoptic intubation in the absence of premedication. Anesthesia 66: 368-372, 2011.
17. Jaakola ML, Ali Melkkilä T, Kanto J, et al: Dexmedetomidine reduces intraocular pressure, intubation responses and anaesthetic requirements in patients undergoing ophthalmic surgery. Br J Anaesth 68: 570-575, 1992.
18. Venn RM, Bradshaw CJ, Spencer R, et al: Preliminary UK experience of dexmedetomidine, a novelagent for postoperative sedation in the intensive care unit. Anaesthesia 54: 1136-1142, 1999. .
19. Cattano D, Lam NC, Ferrario L, et al: Dexmedetomidine versus remifentanil for sedation during awake fiberoptic intubation. Anesthesiol Res Pract 2012: 753107, 2012.
20. Scher CS and Gitlin MC: Dexmedetomidine and low dose ketamine provide adequate sedation for awake fibreoptic intubation. Can J Anaesth 50: 607-610, 2003.
21. Bloor BC, Ward DS, Belleville JP and Maze M: Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology 77: 1134-1142, 1992.
22. Ebert TJ, Hall JE, Barney JA, et al: The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 93: 382-394, 2000.